image
Healthcare - Biotechnology - NASDAQ - US
$ 298.83
-3.67 %
$ 6.6 B
Market Cap
-16.56
P/E
BALANCE SHEET
1.04 B ASSETS
62.71%
288 M LIABILITIES
22.38%
754 M EQUITY
86.11%
BALANCE SHEET DECOMPOSITION
Balance Sheet Madrigal Pharmaceuticals, Inc.
image
Current Assets 1.03 B
Cash & Short-Term Investments 926 M
Receivables 53.8 M
Other Current Assets 52.9 M
Non-Current Assets 9.32 M
Long-Term Investments 0
PP&E 4.59 M
Other Non-Current Assets 4.73 M
88.87 %5.16 %5.07 %Total Assets$1.0b
Current Liabilities 169 M
Accounts Payable 43.6 M
Short-Term Debt 983 K
Other Current Liabilities 125 M
Non-Current Liabilities 119 M
Long-Term Debt 119 M
Other Non-Current Liabilities 0
15.15 %43.32 %41.20 %Total Liabilities$287.9m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2001
ASSETS
Cash & Cash Equivalents 100.0 99.9 331.5 36.3 54.0 46.7 483.7 191.5 40.5 35.0 46.0 48.5 81.5 30.1 31.3 44.2 52.0 115.6 33.7 23.8 42.7 36.1 0
Short Term Investments 826.2 534.2 27.2 234.1 230.1 392.3 426.3 42.9 21.4 31.6 51.7 43.0 19.1 9.7 19.7 0 21.5 0 13.1 38.2 82.2 40.2 0
Receivables 53.8 0 0 0 0 0 0 0 0 7.33 K 0 0 0 0 0.1 0 16.0 0 0 0 0 0 0
Inventory 34.1 0 0 0 0 0 0 0 0 7.33 K 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 18.8 3.1 2.6 2.7 2.0 2.3 3.0 1.0 0.7 50 K 1.7 1.5 1.6 1.1 0.4 0.8 1.7 1.4 0.8 0.9 1.1 0.8 0
Total Current Assets 1 032.9 637.3 361.4 271.7 285.2 440.2 485.2 192.0 41.2 67.8 99.3 92.2 101.4 40.3 51.5 44.6 91.2 117.0 47.6 63.0 126.0 77.1 0
PP&E 4.6 3.3 1.2 1.6 1.8 1.9 0.2 0.3 2.95 K 0.4 1.0 1.6 1.2 1.4 2.2 4.0 5.9 5.6 6.1 8.1 4.8 3.2 0
Intangible Assets 4.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0 0 54 0 0.3 1.4 0.5 0.6 0.4 0.4 0.1 76 K 1.1 0.1 1.2 82 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.8
Total Assets 1 042.2 640.5 362.6 273.3 287.0 442.1 485.4 192.3 41.2 68.2 100.7 95.2 103.0 42.3 54.1 48.9 97.3 122.6 54.8 71.2 132.0 80.4 2.8
LIABILITIES
Accounts Payable 43.6 28.0 23.8 21.4 1.0 1.2 2.5 1.9 0.8 0.1 3.1 6.6 5.7 3.5 1.9 4.0 3.3 2.5 2.6 3.4 2.9 0.2 0
Short Term Debt 1.0 0.5 0.6 0.8 0.6 0.6 0 0 0 48.6 9.3 9.5 8.0 4.2 0.2 1.3 4.3 2.4 2.3 1.9 0.5 0 0
Other Current Liabilities 124.7 90.0 91.5 54.6 44.9 23.3 6.0 8.1 4.0 0.6 18.5 16.1 9.9 7.4 10.0 6.6 13.1 10.5 6.1 8.7 9.0 2.9 0
Total Current Liabilities 169.3 118.5 115.9 76.8 46.6 25.1 8.4 10.1 4.8 17.8 30.9 32.2 23.5 15.1 16.7 16.5 33.3 20.8 11.5 14.5 12.9 3.5 0
Long Term Debt 118.6 116.7 49.3 0.4 0.5 0.4 0 0 0 0 4.7 13.9 4.5 12.4 11.7 0.8 8.3 2.8 3.2 4.3 1.2 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 26 K (0.8) (114.4) (74.2) 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 41.8 0 0 0 0
Total Liabilities 287.9 235.2 165.2 77.2 47.0 25.5 8.4 10.1 4.8 17.8 35.5 46.1 28.0 27.6 30.6 24.0 156.0 97.8 56.5 18.7 14.1 3.5 29 K
EQUITY
Common Stock 2 K 2 K 2 K 2 K 2 K 2 K 2 K 1 K 1.2 K 14 K 11 K 9 K 7 K 5 K 4 K 3 K 3 K 3 K 2 K 2 K 3 K 3 K 1 K
Retained Earnings (1 802.2) (1 336.3) (962.7) (667.3) (425.5) (223.2) (139.3) (106.5) (75.3) (706.2) (637.6) (551.4) (461.2) (398.4) (351.1) (313.6) (392.7) (300.1) (236.6) (179.3) (110.4) (64.5) 0
Other Accumulative Comprehensive Income/Loss 0.5 0.5 32 K 80 K 47 K 0.2 (0.3) 31 K 25.4 K 4 K 4 K 17 K 2 K 3 K 3 K (16.0) 15 K (11.5) 2 K (7.3) (10.6) (2.8) 0
Total Equity 754.4 405.3 197.4 196.1 240.0 416.6 477.0 182.3 36.4 50.4 65.1 49.1 75.1 14.8 23.5 24.9 (58.8) 24.9 (1.7) 52.5 118.0 76.9 2.7
Total Liabilities and Equity 1 042.2 640.5 362.6 273.3 287.0 442.1 485.4 192.3 41.2 68.2 100.7 95.2 103.0 42.3 54.1 48.9 97.3 122.6 54.8 71.2 132.0 80.4 2.8
SHARES OUTSTANDING
Common Shares Outstanding 21.3 18.7 17.1 16.5 15.4 15.4 14.8 12.2 5.2 0.2 2.8 2.0 1.7 1.3 1.2 1.0 1.0 0.9 0.6 0.6 0.5 0.6 0.3 83.7 K